Page 2507

All-In-One Wireless Security System For Home And Business Property Protection — Foscam Introduces New Indoor/Outdoor 720P WiFi Wireless Security System With 4 Weatherproof IP Cameras And 1TB Network Video Recorder

0

HOUSTON, April 27, 2017 /PRNewswire-HISPANIC PR WIRE/ — Foscam Inc., a global provider of IP Camera solutions and surveillance products, introduces a new all-in-one, easy to install wireless security system, Foscam’s FN3104W-B4. The compact system operates through a wireless network so no wiring is needed. Installation is simple with plug-and-play setup.

Foscam’s all-in-one system includes advanced security features. The 4 bullet cameras have flexible mounting positions and can be mounted indoors and out. After being powered, the cameras can connect to the NVR in the same system automatically. Connecting the NVR to the router allows remote viewing access. Automatic channel selection for sustained WiFi speeds is included. The system automatically selects the best channel to get a more stable network connection and boost WiFi speed. The bandwidth-friendly streaming provides optimum video viewing while saving bandwidth for other smart devices such as TVs, tablets and phones. 

Consumers can securely view and control the system locally and remotely through online access and the free Foscam NVR iOS and Android mobile apps. The 1TB hard drive is preinstalled and offers 24/7 recording and 14 day playback history. The 30 Infrared IR-LEDs provide 66-feet IR range of clear night vision. The weatherproof IP66-rated housing ensures protection against harsh weather year round with an operating temperature range of 14-140 degrees Fahrenheit.

Foscam FN3104W-B4 Security System Features

  • NVR and cameras auto-connect to wireless network, easy setup
  • 4-CH live viewing and 4-CH synchronous playback with sharp 720P HD video
  • Remote and local viewing via Foscam NVR App, browsers like IE, Firefox, Safari or monitor display
  • 24/7 recording by supporting hard drive up to 4TB and 66ft IR range
  • Smart motion detection alerts push to email & FTP, alerts when something’s up

Foscam introduces The FN3104W-B4 720P WIFI NVR Security System For $349.99 MSRP. Save 15% with Amazon Deal good through May 6, 2017

About Foscam Inc.
Foscam Inc. helps consumers secure and share their world from any place at any time. An innovative designer, developer, and manufacturer of IP surveillance products, Foscam has sold millions of security and surveillance products in more than 60 countries with operations around the world. Foscam is committed to providing consumers the safest, most affordably priced wireless security cameras, equipment and solutions on the market today.

Foscammall.com

YouTube, Facebook Twitter

Chase Rhymes
832.549.4119
[email protected]

Video – http://www.youtube.com/watch?v=ymamm_7v9uU

FIBRA Prologis Announces Results from Annual and Extraordinary Certificate Holders Meeting

0
FIBRA Prologis.

MEXICO CITY, April 27, 2017 /PRNewswire-HISPANIC PR WIRE/ — FIBRA Prologis (BMV: FIBRAPL14), a leading owner and operator of Class-A industrial real estate in Mexico, today announced the approval of the proposals presented at its annual and extraordinary certificate holders meetings.

Approximately 78.7 percent of the Certificados Bursátiles Fiduciarios Inmobiliarios (CBFIs) were represented in the meetings.

The following proposals were approved by a majority vote:

  • Ratification of the appointment of independent members (proprietary and alternates) of the technical committee and confirmation of their independence as per applicable law
  • Ratification of the compensation of independent members (proprietary and alternate) of the technical committee
  • 2016 annual audited financial statements
  • 2016 annual report
  • Appointment of special delegates to execute the resolutions

In the Extraordinary Holders Meeting the proposal of a certificate buyback program was approved by a majority vote.

ABOUT FIBRA PROLOGIS
FIBRA Prologis is a leading owner and operator of Class-A industrial real estate in Mexico. As of March 31, 2017, FIBRA Prologis was comprised of 194 logistics and manufacturing facilities in six industrial markets in Mexico totaling 34.2 million square feet (3.2 million square meters) of gross leasable area.

FORWARD-LOOKING STATEMENTS

The statements in this release that are not historical facts are forward-looking statements. These forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which FIBRA Prologis operates, management’s beliefs and assumptions made by management.  Such statements involve uncertainties that could significantly impact FIBRA Prologis financial results. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature.  All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to rent and occupancy growth, acquisition activity, development activity, disposition activity, general conditions in the geographic areas where we operate, our debt and financial position, are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. Some of the factors that may affect outcomes and results include, but are not limited to: (i) national, international, regional and local economic climates, (ii) changes in financial markets, interest rates and foreign currency exchange rates, (iii) increased or unanticipated competition for our properties, (iv) risks associated with acquisitions, dispositions and development of properties, (v) maintenance of real estate investment trust (“FIBRA”) status and tax structuring, (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, and (ix) those additional factors discussed in reports filed with the “Comisión Nacional Bancaria y de Valores” and  the Mexican Stock Exchange by FIBRA Prologis under the heading “Risk Factors.” FIBRA Prologis undertakes no duty to update any forward-looking statements appearing in this release.

Non-Solicitation – Any securities discussed herein or in the accompanying presentations, if any, have not been registered under the Securities Act of 1933 or the securities laws of any state and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act and any applicable state securities laws. Any such announcement does not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein or in the presentations, if and as applicable.

FIBRA Prologis.

Logo – https://mma.prnewswire.com/media/124472/fibra_prologis_logo.jpg

 

Nine Members of Congress Honored for Efforts to Preserve Access to Quality Medical Eye Care

0
US_Capital_2

WASHINGTON, April 27, 2017 /PRNewswire-HISPANIC PR WIRE/ — The American Academy of Ophthalmology is honoring nine members of Congress whose legislative efforts are helping to preserve patient access to quality medical eye care. The Academy is presenting its 2017 Visionary Awards to Sen. Susan Collins, R-Maine, Sen. Chuck Grassley, R-Iowa, Sen. Claire McCaskill, D-Mo., Sen. Chuck Schumer, D-N.Y., Rep. Diana DeGette, D-Colo., Rep. John Lewis, D-Ga., Rep. Doris Matsui, D-Calif., Rep. Peter Roskam, R-lll., and Rep. Kyrsten Sinema, D-Ariz.

US_Capital_2

The Academy presents its Visionary Award each year in conjunction with its annual legislative visit to Capitol Hill. This honor recognizes federal legislators for important efforts to advocate for enhancing and preserving access to quality eye care in the United States.

Sens. Collins and McCaskill have worked to ensure continued access to compounded and repackaged medications. These are treatments administered by ophthalmologists – physicians who specialize in medical and surgical eye care – to patients who suffer from wet age-related macular degeneration and other sight-threatening diseases. Sens. Collins and McCaskill are also prominent investigators of sudden drug price increases that compromise patient access.

Sen. Schumer and Reps. DeGette and Sinema were instrumental in a joint effort in the U.S. Senate and House of Representatives to compel the Centers for Medicare & Medicaid Services to reconsider adopting a flawed Medicare Part B drug demonstration. If adopted, CMS’ proposal would have jeopardized Medicare patients’ access to critical eye care treatments.

Sen. Grassley and Reps. Roskam and Lewis used their Medicare oversight roles to ensure the sustainability of ophthalmology in rural communities. They pressured CMS into reconsidering a severe Medicare reimbursement rate cut for glaucoma and retinal detachment procedures. Their efforts preserved the continued availability of these sight-threatening treatments that disproportionately impact minority and rural communities across the country.

Rep. Matsui is leading efforts to improve the federal program that governs the use of electronic health records for Medicare patients. Her work ensures that physicians have fewer administrative barriers that distract from their interactions with their patients.

“The nation’s ophthalmologists are proud of our congressional lawmakers who are working to ensure that patients in every community have timely access to critical treatments for eye diseases,” said Cynthia A. Bradford, M.D., president of the American Academy of Ophthalmology. “The Academy is committed to fostering these partnerships within Congress to ensure that our patients can receive the highest-quality medical and surgical eye care.”

The Academy is the leading voice for the profession of ophthalmology in Washington. The organization takes an active role in working with Congress and government agencies on policy issues that affect how medical and surgical care is provided in the United States.

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit www.aao.org.

AAO Logo

Photo –  http://mma.prnewswire.com/media/494939/US_Capital_2.jpg

Logo – http://mma.prnewswire.com/media/287412/american_academy_of_ophthalmology_Logo.jpg

Artificial Intelligence Shows Potential to Fight Blindness

0
american_academy_of_ophthalmology_Logo

SAN FRANCISCO, April 27, 2017 /PRNewswire-HISPANIC PR WIRE/ — Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of diabetes that affects the eyes. This advance has the potential to reduce the worldwide rate of vision loss due to diabetes.

american_academy_of_ophthalmology_Logo

In a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology, the researchers describe how they used deep-learning methods to create an automated algorithm to detect diabetic retinopathy. Diabetic retinopathy (DR) is a condition that damages the blood vessels at the back of the eye, potentially causing blindness.

“What we showed is that an artificial intelligence-based grading algorithm can be used to identify, with high reliability, which patients should be referred to an ophthalmologist for further evaluation and treatment,” said Theodore Leng, M.D., lead author. “If properly implemented on a worldwide basis, this algorithm has the potential to reduce the workload on doctors and increase the efficiency of limited healthcare resources. We hope that this technology will have the greatest impact in parts of the world where ophthalmologists are in short supply.” 

Another advantage is that the algorithm does not require any specialized, inaccessible, or costly computer equipment to grade images. It can be run on a common personal computer or smartphone with average processors.

Deep learning is on the rise in computer science and medicine because it can teach computers to do what our brains do naturally. What Dr. Leng and his colleagues did was to create an algorithm based on more than 75,000 images from a wide range of patients representing several ethnicities, and then used it to teach a computer to identify between healthy patients and those with any stage of disease, from mild to severe.

Dr. Leng’s algorithm could identify all disease stages, from mild to severe, with an accuracy rate of 94 percent. It would be these patients that should see an ophthalmologist for further examination. An ophthalmologist is a physician who specializes in the medical and surgical treatment of eye diseases and conditions.

Diabetes affects more than 415 million people worldwide or 1 in every 11 adults.1 About 45 percent of diabetic patients are likely to have diabetic retinopathy at some point in their life; however, fewer than half of patients are aware of their condition. Early detection and treatment are integral to combating this worldwide epidemic of preventable vision loss.

Ophthalmologists typically diagnose the presence and severity of diabetic retinopathy by direct examination of the back of the eye and by evaluation of color photographs of the fundus, the interior lining of the eye. Given the large number of diabetes patients globally, this process is expensive and time-consuming. Also, previous studies have shown that detection is somewhat subjective, even among trained specialists. This is why an effective, automated algorithm could potentially reduce the rate of worldwide blindness.

Approval from the U.S. Food and Drug Administration is required before the algorithm can be used in patients on a broad basis. Dr. Leng and his team expect to conduct pilot trials in the near future.

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.

About Ophthalmology
Ophthalmology, the official journal of the American Academy of Ophthalmology, publishes original, peer-reviewed, clinically-applicable research. Topics include the results of clinical trials, new diagnostic and surgical techniques, treatment methods, technology assessments, translational science reviews and editorials. For more information, visit www.aaojournal.org.

[1] International Diabetes Federation (IDF). IDF Diabetes Atlas 7th edition. (Accessed October 20, 2016); 2015

Logo – https://mma.prnewswire.com/media/287412/american_academy_of_ophthalmology_Logo.jpg

Congress Hears From Ophthalmologists on Issues Affecting Medical and Surgical Eye Care

0
American_Academy_of_Ophthalmology_US_Capital

WASHINGTON, April 27, 2017 /PRNewswire-HISPANIC PR WIRE/ — Eye physicians and surgeons representing the American Academy of Ophthalmology are engaging Congress in Washington, D.C., today on behalf of millions of patients across the United States who require medical and surgical eye care. During meetings with their respective members of the U.S. Senate and House of Representatives, ophthalmologists will raise critical issues that impact the quality of care their patients receive.

American_Academy_of_Ophthalmology_US_Capital

Their visit comes at a critical time as policy makers continue to consider options for reforming and improving the nation’s health care system. As the leading professional organization for more than 17,000 of the nation’s practicing ophthalmologists, the Academy plays a critical role in helping elected officials and policymakers understand the complexities of delivering medical and surgical eye care.

Ophthalmologists are emphasizing during these meetings their commitment to ensuring that patients have access to affordable, highest-quality eye care. When the delivery of health care is affected, the Academy advocates for Congress to allow the following to guide their legislative and regulatory decisions:

  • Making the treatment of eye disease available and affordable for all Americans;
  • Requiring insurance plans to have adequate provider networks to ensure patient access to covered specialty and subspecialty services;
  • Reducing regulatory burdens that detract from patient care, interfere with the patient-physician relationship, introduce inefficiencies or increase costs;
  • Providing greater cost transparency and promoting economic efficiency throughout the health care system;
  • Ensuring timely access to treatments that are proven to be effective in patient care, while preserving physicians’ ability to determine what is appropriate for their patients;
  • Improving quality and safety by encouraging initiatives and technology that provide a verifiable mechanism to validate clinically relevant improvements in patient outcomes;
  • Ensuring that policies reflect the diversity of provider practices, including practice size, geography, access to specialized technology and facilities, and special needs of the patient populations they serve; and
  • Recognizing that the special needs of patient populations may be based on racial, ethnic, cultural, geographic, health and economic factors.

“Our nation’s health care system is facing one of the most critical inflection points in our history,” said David W. Parke II, M.D., CEO of the American Academy of Ophthalmology. “The delivery of health care in this country is indeed complex and expensive. As our elected leaders continue to debate its future, the ophthalmology community remains committed to working toward solutions that provide patients with the care they require, when they need it.”

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit www.aao.org.

AAO Logo

Photo – http://mma.prnewswire.com/media/494936/American_Academy_of_Ophthalmology_US_Capital.jpg

Logo – http://mma.prnewswire.com/media/287412/american_academy_of_ophthalmology_Logo.jpg

Atreseries Internacional premieres a new season of the series ‘Allí Abajo’

0
ATRESERIES Logo

MADRID, April 27, 2017 /PRNewswire-HISPANIC PR WIRE/ — On Tuesday, May 2nd, Atreseries Internacional is premiering the third season of Allí Abajo’ (‘Down There’), a comedy that divides the heart of the audience between north and south.

ATRESERIES  Logo

Having now become one of the most successful Spanish series in recent years, ‘Allí Abajo’ is preparing all kinds of surprises while maintaining its distinctive characteristics: humor, entertainment, plots involving the whole cast, lots of outdoor scenes and a high degree of mobility for settings and characters, which will come across as an increase in the role of the north.  

The premier will take place next Tuesday on Atreseries Internacional and the audience of this series is in luck, because with 16 episodes, this third season is the longest one so far, and will feature the addition of Elena IruretaNerea Garmendia and Gorka Otxoa, playing three new characters that will drive more than one person crazy.

Outlook for the third season  

If there’s one thing that characterizes the third season of ‘Allí Abajo’ it’s that no one will be where they’re supposed to be, or with whom they’re supposed to be. 

Carmen (María León) and Iñaki (Jon Plazaola) have dug in up north. Newlyweds, with their whole lives before them… well, what could go wrong? What’s more, and due to a most unfortunate incident suffered by don Benjumea (Mariano Peña), the north-south world will start to come unglued, and more than ever before, the characters will have to learn to live with the other ones. Some from the north will have to head south and some from the south will have to make the move north.  Yet it’s not a matter of just this one change, but about identity itself; to the point that a certain character will end up questioning his own sexual orientation.  This season anything can happen.  

Link for download:
http://oficinaprensa.atresmedia.com/ALLIABAJO_T3.mp4 

Link for download of photos:
http://oficinaprensa.antena3.com/Jon Plazaola_Foto Roberto Garver 0044.jpg 
http://oficinaprensa.atresmedia.com/AlliAbajo_A3EriesINT2.jpg 
http://oficinaprensa.atresmedia.com/ALLIABAJO_A3SeriesInt1.jpg

BROADCAST TIMES

PREMIERE, Tuesday, May 2nd

  • 8:00 pmMexico and Colombia
  • 9:00 pm/ Venezuela/Puerto Rico
  • 10:00 pm/ Argentina, Chile, Uruguay

U.S.

  • 9:00 pm ET
  • 6:00 pm PT

 

Logo – http://mma.prnewswire.com/media/494700/LOGO_ATRESERIES_Logo.jpg

 

FIBRA Prologis Declares Quarterly Distribution

0
fibra_prologis_logo

MEXICO CITY, April 26, 2017 /PRNewswire-HISPANIC PR WIRE/ — FIBRA Prologis (BMV: FIBRAPL 14), the leading owner of Class-A logistics real estate in Mexico, today declared a cash distribution of Ps. 343.3 million (US$ 18.3 million), or Ps. 0.5410 per Certificado Bursátil Fiduciario Inmobiliario (“CBFI”) (US$ 0.0288 per CBFI) related to the results of the quarter ending March 31, 2017.

The distribution is payable May 5, 2017 to CBFI holders with an ex-dividend date of May 2, 2017 and a record date of May 4, 2017.

ABOUT FIBRA PROLOGIS

FIBRA Prologis is the leading owner and operator of Class-A industrial real estate in Mexico. As of March 31, 2017, FIBRA Prologis was comprised of 194 logistics and manufacturing facilities in six industrial markets in Mexico totaling 34.2 million square feet (3.2 million square meters) of gross leasable area.

FORWARD-LOOKING STATEMENTS

The statements in this release that are not historical facts are forward-looking statements. These forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which FIBRA Prologis operates, management’s beliefs and assumptions made by management.  Such statements involve uncertainties that could significantly impact FIBRA Prologis financial results. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature.  All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to rent and occupancy growth, acquisition activity, development activity, disposition activity, general conditions in the geographic areas where we operate, our debt and financial position, are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. Some of the factors that may affect outcomes and results include, but are not limited to: (i) national, international, regional and local economic climates, (ii) changes in financial markets, interest rates and foreign currency exchange rates, (iii) increased or unanticipated competition for our properties, (iv) risks associated with acquisitions, dispositions and development of properties, (v) maintenance of real estate investment trust (“FIBRA”) status and tax structuring, (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, and (ix) those additional factors discussed in reports filed with the “Comisión Nacional Bancaria y de Valores” and  the Mexican Stock Exchange by FIBRA Prologis under the heading “Risk Factors.” FIBRA Prologis undertakes no duty to update any forward-looking statements appearing in this release.

Non-Solicitation – Any securities discussed herein or in the accompanying presentations, if any, have not been registered under the Securities Act of 1933 or the securities laws of any state and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act and any applicable state securities laws. Any such announcement does not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein or in the presentations, if and as applicable.

fibra_prologis_logo

Logo – https://mma.prnewswire.com/media/124472/fibra_prologis_logo.jpg

Padis Jewelry Announces Spring Tacori Weekend 2017 with Special Pricing

0

SAN FRANCISCO, April 26, 2017 /PRNewswire-HISPANIC PR WIRE/ — Padis Jewelry is proud to announce The Spring Tacori Weekend Event, where fans of elegant handcrafted designer jewelry can experience over 500 rings in person. Purchasers will receive up to $1000 back, and receive a vacation package voucher! The entire line of Tacori engagement rings, Tacori anniversary bands, Tacori wedding bands and Tacori fine lifestyle jewelry will be available on site.

Photo – https://mma.prnewswire.com/media/494708/padis_tacori_spring.jpg

Get your VIP Guest Pass at www.padisgems.com/tacori2017

Padis Jewelry is the only option for Bay Area residents who take pride in shopping local and supporting family business.

Padis also values memories made while traveling with loved ones, so they have teamed up with Wyndham Hotels to offer a FREE 3-night stay in any of their hotels with qualifying purchase ($3995 or more*) of any Tacori Jewelry during the 3-day event. Alternatively, they offer a FREE 2-day cruise for two for those who want to enjoy their Tacori purchase while on the sea!

Aside from the daily unbeatable pricing offered on certified conflict-free diamonds, see the special event pricing*:

  • Get a $100 Gift Card with Tacori purchase from $1,000-$2,499
  • Get a $250 Gift Card with Tacori purchase from $2,500-$4,999
  • Get a $500 Gift Card with Tacori purchase from $5,000-$9,999
  • Get a $1,000 Gift Card with Tacori purchase +$10,000

The THREE-DAY EVENT will feature the complete collection of over 500 Tacori engagement rings and wedding bands, and fine jewelry direct from Tacori’s headquarters in Hollywood.

EVENT DETAILS:
http://www.padisgems.com/tacori2017

April 28th

101 Utah St.
Suite 201

San Francisco

10AM – 5PM
(415) 626-8288

 

April 29th

888 Brannan St.,
Suites 128 & 165

San Francisco

10AM – 5PM
(415) 861-5388

April 30th
1269 Main St.,
St. Helena
11AM – 6PM
(707) 963-2288

ABOUT PADIS JEWELRY:
As San Francisco’s most trusted family jeweler, Padis offers an unparalleled level of customer service and an outstanding selection of the highest-quality diamonds, fine designer jewelry and luxury timepieces. Padis Jewelry has been helping clients mark the moment of special occasions and milestone events for over 40 years, and prides themselves on personalized service and exceptional value.

*All offers are for pre-sales tax purchase amounts made during the event only. Some restrictions may apply. See stores for details.

CONTACT:
Alexis Padis
(415) 861-5388
[email protected]

 

Transplant survivors meet donors for first time at City of Hope’s 41st Annual Bone Marrow Transplant Reunion

0

A father of three and an aplastic anemia survivor who helped wife beat breast cancer join thousands to thank donors at the April 28 event

DUARTE, California, April 26, 2017 /PRNewswire-HISPANIC PR WIRE/ — When Sergio Ramirez came to City of Hope in early 2013, the acute lymphoblastic leukemia (ALL) he thought he had overcome after three years of treatment had just returned, stronger. A biopsy revealed that 82 percent of his bone marrow cells were leukemic cells. The Los Angeles father of three boys was terrified about what loomed ahead.

“If the first three years of chemotherapy and maintenance did not work, I thought, ‘What am I going to go through now?'” said Ramirez, 34, who knew that patients whose ALL has relapsed have only a roughly 15 percent chance of survival. ALL is a cancer that starts in white blood cells, produces cancerous cells and can quickly spread to a body’s organs.

“I was terrified but I didn’t show that because of my kids. I just wanted them to see that Daddy was strong and that he was going to be there for them,” he added.

Ramirez’s doctor had referred him to City of Hope to take part in an immunotherapy trial led by Anthony Stein, M.D., co-director of City of Hope’s Gehr Family Center for Leukemia Research. Ramirez took two 28-day cycles of a drug, which spurred his immune cells to attack the leukemia cells and put his cancer in remission.

Ramirez still needed a bone marrow transplant so he could remain cancer-free, and received one a few weeks later. He’s thought often about the unrelated donor who came forward to save the life of a person he had never met.

On Friday, April 28, Ramirez will finally thank his donor at City of Hope’s 41st Annual Bone Marrow Transplant (BMT) Reunion. For Ramirez, that day couldn’t come sooner.

“I’m here with my kids, thanks mostly because of his generosity,” said Ramirez, who recalled that a donor who had first been identified didn’t go through with the donation. “Every time I think about it, I just want to cry … I really do want to meet him and thank him so much because without him, I don’t know if I would still be here.”

Another patient, Evan Braggs, will also meet his donor at the BMT reunion

Rancho Cucamonga resident Evan Braggs, 32, is also elated to meet his donor at this year’s BMT reunion.

It’s long overdue – Braggs received his transplant in 2005. He was 20 years old and battling a devastating blood disease, aplastic anemia. The disease prevents a person’s blood marrow from making an adequate amount of new blood cells, and can eventually lead to severe heart problems.

As Braggs played basketball one day, he ran out of breath and fell to the ground.

“I had to lie down for like 15 minutes,” he recalled. The next morning, his father took him to a local hospital, where medical staff tested his blood twice because they wanted to make sure the diagnosis was correct. Braggs’ hemoglobin levels were so low that he was immediately admitted to the intensive care unit and given a blood transfusion.

“One of the nurses mentioned to me I was about two weeks away from having a heart attack,” he added.

The diagnosis shocked Braggs. He had never had as much as a broken bone, and at the time, he ran hurdles for the Mt. San Antonio College track team. He also played basketball and worked out every day. “Looking at me, you would not have known how sick I was,” he added.

At City of Hope, Ryotaro Nakamura, M.D., associate professor of hematology and hematopoietic cell transplantation, treated Braggs with two serums in an attempt to boost his bone marrow production. He also received blood transfusions every few weeks. But in order to cure the anemia, he would need a BMT.

Braggs was determined not to let his treatment affect his school, and he worked closely with Nakamura to schedule his transplant during his summer break. He spent that summer in the hospital as he recovered from the transplant.

Those weeks at City of Hope helped Braggs value his young life, as well as appreciate the multitude of people who helped him regain his health.

“I’m very thankful that this gentleman took the time out of his life to do something like that … and also thankful for so many people that were involved in the process of getting me along, from my parents to Dr. Nakamura to the nurses to the nurse practitioners,” Braggs said.

He never thought he could pay any of that kindness forward, but the opportunity came several years later.

Braggs had just met a young woman, Natalia Melina, when she was diagnosed with Stage 2 breast cancer in January 2014.

The 32-year-old woman recalls she told Braggs about her diagnosis, and that he didn’t have to be involved since he had been through his own treatment before. Braggs said he wouldn’t have it any other way, and recommended she receive treatment at City of Hope, which she did. The two eventually started dating, and when she received chemotherapy and lost her hair, Braggs shaved his head, too.

“I was able to speak about all the things you go through with treatment – losing your hair, chemo-sickness, fatigue, things of that nature – and help put her at ease and get her to the next part of treatment,” he added.

The couple married in 2015.

“We reflect now and think that we’ve already experienced those difficult moments most people can only talk about in their vows,” Braggs said. “In sickness or in health. For better or for worse. We went through the worst and stayed together through all of it.”

About BMT

BMTs offer a second chance for people with life-threatening blood cancers and other hematologic malignancies. Since 1976, more than 13,000 patients from virtually every state and dozens of countries have undergone bone marrow, cord blood or stem cell transplants at City of Hope.

City of Hope has the only transplant program in the nation to achieve 12 consecutive reporting years of “over performance” in one-year overall patient survival, according to the most recent data from the Center for International Blood and Marrow Transplant Research.

In addition, City of Hope is bridging the way to the next frontier in treating these cancer patients: using immunotherapy to train a patient’s immune system to fight cancer. Amid the transplant survivors at the reunion are a handful of patients who represent a new generation of blood cancer survivors: patients treated in clinical trials with T cell immunotherapy. These patients’ own immune cells were extracted, modified to enable them to recognize and attack cancer cells, and then reinfused back into the patients.

About City of Hope’s BMT reunion

City of Hope has hosted an annual reunion for BMT survivors such as Ramirez and Braggs for the past 41 years. What began with a birthday cake and a single candle representing a patient’s first year free from cancer has grown into an annual picnic extravaganza that draws more than 4,000 survivors, donors and families from around the world, as well as the doctors, nurses and staff who help them through the lifesaving therapy.

The patient-donor meetings are the event’s emotional highlight. Many recipients, though overwhelmed with curiosity and the need to express their gratitude, can only dream of meeting the strangers who saved their lives. City of Hope makes that dream come true for two patients every year.

“The reunion highlights what research, and exceptional nursing and physician care, have accomplished to save the lives of patients,” said Stephen J. Forman, M.D, Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation at City of Hope. “It emphasizes we are all connected to each other and the many joys in life that a patient is able to experience once they have been cured by a transplant.”

Ramirez, Braggs and their donors will be the highlight of a 10 a.m. news conference on the City of Hope campus – the Argyros Family Garden of Hope, located in front of City of Hope Helford Clinical Research Hospital.

Later that afternoon, City of Hope will host a program of entertainment for survivors, donors and families.

About City of Hope

City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as one of only 47 comprehensive cancer centers, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the world. City of Hope is located in Duarte, California, just northeast of Los Angeles, with community clinics throughout Southern California. It is ranked as one of “America’s Best Hospitals” in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation, diabetes and numerous breakthrough cancer drugs based on technology developed at the institution. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.

Infertility Awareness Week Reminds Us That 48.5 Million Couples Worldwide Need Fertility Help

0

LOS ANGELES, April 26, 2017 /PRNewswire-HISPANIC PR WIRE/ — Nestled on a 1,500-acre private peninsula on the north end of Banderas Bay in the Mexican state of Nayarit, Punta Mita is known as a top vacation spot for household names like Jennifer Lawrence, Vince Vaughn, and Kylie Jenner, as well as tech titans like Bill Gates. Recognizing the need for accessible healthcare services for this residential community and resort, Los Angeles-based industry veteran and fertility specialist Dr. Sam Najmabadi, along with additional investors, will open the first full-service hospital, Punta Mita Hospital, in May 2017.

Photo – https://mma.prnewswire.com/media/494322/Headshot_Sam_Najmabadi.jpg

Dr. Najmabadi, a multiple Top 10 Doctor and Patients’ Choice Award recipient, had the idea for the hospital when he and his wife decided they wanted to retire in Punta Mita. “We started looking at available medical services and realized there was a need for improvement. We felt we could deliver high quality, compassionate care combined with the latest in technology and cutting edge medicine to this piece of paradise.” Widely regarded as a leader in his field in fertility and reproductive health and having worked with a number of Hollywood’s biggest celebrities, Dr. Najmabadi’s mission is always to provide the highest quality fertility care. His high success rates per SART/CDC reporting system are unparalleled.

With the help of Dr. Najmabadi, the 13,000 square foot hospital will rival some of the most advanced medical establishments in the U.S by bringing state-of-the-art technology and equipment to Mexico. According to the World Health Organization, 48.5 million couples worldwide were unable to have a child. Punta Mita Hospital is hoping to combat that number by being the first in Mexico to carry the embryoscope. The embryoscope is an incubator that holds an embryo for 3-5 days and features time-lapse photography. It photographs the embryos every 7 minutes at different depths and allows doctors to have real time evaluation, which improves success rates significantly. Punta Mita Hospital will also be releasing it’s own app that provides 911 related technology and location tracking for ER services.

www.puntamitahospital.com